St. Jude Medical slides on potential FDA warning, lowered outlook

October 17, 2012 by MassDevice staff

Shares of St. Jude Medical are down more than 6% today after the medical device company said it might get a warning letter from the FDA over a California plant and lowered its outlook for the rest of the year.

St. Jude Medical

St. Jude Medical's (NYSE:STJ) stock took a hit today after the medical device company said it might get a warning from the FDA over one of its California factories and lowered its outlook for the rest of the year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp